Learn to Customize Your Own Options Trading Strategy
This guide will help you evaluate and analyze your trading plan to create a custom options trading strategy tailored to your risk profile and market outlook. Learn how to take your trading to the next level.
Download your FREE Options Strategy Guide Today!
Paul Kim, insider at Fulgent Genetics
Paul Kim Insider Alerts

Get notified the next time Paul Kim buys or sells Fulgent Genetics stock. Enter your email address below to get our daily insider buying and selling report.

Paul Kim Insider Information

Paul Kim is the CFO at Fulgent Genetics, a role he has held since 2016. Fulgent is a leader in next generation sequencing, dedicated to creating affordable and flexible genetic testing.

Prior to joining Fulgent, Kim was the CFO for Cogent Systems, a manufacturer of automated fingerprint identification and facial recognition systems. The company was acquired by 3M in 2010. Cogent’s founder, Ming Hsieh, went on to found Fulgent in 2011, where Kim would later join him after a brief period of retirement. 

Before his tenures at Cogent and Fulgent, Kim served in executive finance positions for a variety of companies, including JNI Corporation, a storage area network technology company, Datafusion, a software development company, and Interlink Computer Sciences, an enterprise software company. He also worked as an audit manager at Coopers and Lybrand L.L.P.

Kim earned his bachelor’s degree in economics at the University of California, Berkeley, and he is a certified public accountant.

What is Paul Kim's net worth?

The estimated net worth of Paul Kim is at least $11.06 million as of September 2nd, 2021. Mr. Kim owns 135,176 shares of Fulgent Genetics stock worth more than $11,057,397 as of December 5th. This net worth estimate does not reflect any other assets that Mr. Kim may own. Learn More.

What is Paul Kim's salary?

As the CFO of Fulgent Genetics, Inc., Mr. Kim earned a total compensation package of $1,390,456.00 in 2020. Mr. Kim earned a salary of $210,000.00, a bonus of $8,000.00, stock awards of $1,136,800.00, and other compensation of $35,656.00.

How do I contact Paul Kim?

The corporate mailing address for Mr. Kim and other Fulgent Genetics executives is 4978 SANTA ANITA AVENUE, TEMPLE CITY CA, 91780. Fulgent Genetics can also be reached via phone at (626) 350-0537 and via email at [email protected]

Has Paul Kim been buying or selling shares of Fulgent Genetics?

Over the course of the past ninety days, Paul Kim has sold $208,120.00 of Fulgent Genetics stock. Most recently, Paul Kim sold 500 shares of the business's stock in a transaction on Thursday, November 18th. The shares were sold at an average price of $97.46, for a transaction totalling $48,730.00.

Who are Fulgent Genetics' active insiders?

Fulgent Genetics' insider roster includes John Bolger (Director), Hanlin Gao (Insider), Paul Kim (CFO), and Jian Xie (COO).

Are insiders buying or selling shares of Fulgent Genetics?

During the last twelve months, Fulgent Genetics insiders bought shares 1 times. They purchased a total of 16,492 shares worth more than $1,632,378.16. During the last twelve months, insiders at the sold shares 24 times. They sold a total of 104,193 shares worth more than $9,487,893.59. The most recent insider tranaction occured on November, 29th when COO Jian Xie sold 636 shares worth more than $60,687.12. Insiders at Fulgent Genetics own 31.0 % of the company.

Information on this page was last updated on 11/29/2021.

Paul Kim Insider Trading History at Fulgent Genetics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/18/2021Sell500$97.46$48,730.00View SEC Filing Icon  
11/16/2021Sell1,669$95.50$159,389.50View SEC Filing Icon  
9/2/2021Sell607$94.29$57,234.03135,176View SEC Filing Icon  
8/16/2021Sell1,682$95.12$159,991.84View SEC Filing Icon  
6/4/2021Sell789$74.26$58,591.14142,977View SEC Filing Icon  
6/2/2021Sell461$71.34$32,887.74142,977View SEC Filing Icon  
5/25/2021Sell10,358$72.94$755,512.52161,438View SEC Filing Icon  
5/18/2021Sell1,155$70.71$81,670.05171,796View SEC Filing Icon  
12/9/2020Sell10,662$51.60$550,159.20191,521View SEC Filing Icon  
12/2/2020Sell29,949$46.58$1,395,024.42231,502View SEC Filing Icon  
11/16/2020Sell100,000$46.17$4,617,000.00235,899View SEC Filing Icon  
9/2/2020Sell425$28.32$12,036.00335,899View SEC Filing Icon  
8/19/2020Sell136,643$42.12$5,755,403.16471,109View SEC Filing Icon  
8/17/2020Sell111,236$41.65$4,632,979.40471,109View SEC Filing Icon  
8/11/2020Sell1,396$42.06$58,715.76472,417View SEC Filing Icon  
6/2/2020Sell425$18.06$7,675.50433,813View SEC Filing Icon  
5/12/2020Sell1,421$16.31$23,176.51434,238View SEC Filing Icon  
8/12/2019Sell12,389$11.50$142,473.50412,250View SEC Filing Icon  
5/13/2019Sell1,404$5.50$7,722.00View SEC Filing Icon  
3/5/2019Sell1,165$4.67$5,440.55400,015View SEC Filing Icon  
11/13/2018Sell1,446$3.50$5,061.00View SEC Filing Icon  
8/13/2018Sell1,405$4.50$6,322.50382,626View SEC Filing Icon  
5/14/2018Sell1,370$3.72$5,096.40384,031View SEC Filing Icon  
3/8/2018Sell1,628$3.76$6,121.28385,401View SEC Filing Icon  
11/13/2017Sell1,573$3.22$5,065.06View SEC Filing Icon  
8/11/2017Sell6,134$5.71$35,025.14388,602View SEC Filing Icon  
See Full Table

Paul Kim Buying and Selling Activity at Fulgent Genetics

This chart shows Paul Kim's buying and selling at Fulgent Genetics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Fulgent Genetics Company Overview

Fulgent Genetics logo
Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. It offers genes and panels, known mutation, hereditary cancer, carrier screening, and tumor profiling solutions. The company was founded on May 13, 2016 and is headquartered in Temple City, CA.
Read More

Today's Range

Now: $81.80
Low: $78.92
High: $85.45

50 Day Range

MA: $85.66
Low: $77.30
High: $98.32

2 Week Range

Now: $81.80
Low: $41.60
High: $189.89

Volume

509,213 shs

Average Volume

557,458 shs

Market Capitalization

$2.44 billion

P/E Ratio

4.26

Dividend Yield

N/A

Beta

1.34
Learn to Customize Your Own Options Trading Strategy
This guide will help you evaluate and analyze your trading plan to create a custom options trading strategy tailored to your risk profile and market outlook. Learn how to take your trading to the next level.
Download your FREE Options Strategy Guide Today!